| Page 31 | Kisaco Research

The UPC’s Milan Division has drawn new lines on procedural efficiency- finding both excessive invalidity attacks and late-filed arguments unacceptable. This 15 minute update examines the bioMérieux v Labrador decision and its implications for how defendants and plaintiffs must now calibrate their litigation strategy before the UPC.

Author:

Aloys Hüttermann

Patent Attorney
Michalski Hüttermann

Aloys Hüttermann

Patent Attorney
Michalski Hüttermann
 

Daniel Haders, PhD

Chief Executive Officer & Founder
Model Medicines

Daniel Haders, PhD

Chief Executive Officer & Founder
Model Medicines

Daniel Haders, PhD

Chief Executive Officer & Founder
Model Medicines
 

Kunal Jindal

Co-Founder & Chief Technology Officer
CapyBio

Kunal Jindal

Co-Founder & Chief Technology Officer
CapyBio

Kunal Jindal

Co-Founder & Chief Technology Officer
CapyBio
 

Rafael Carazo Salas

Founder & Chief Executive Officer
CellVoyant

Rafael Carazo Salas

Founder & Chief Executive Officer
CellVoyant

Rafael Carazo Salas

Founder & Chief Executive Officer
CellVoyant
 

Adrian Grzybowski

Chief Scientific Officer
AnuBio

Adrian Grzybowski

Chief Scientific Officer
AnuBio

Adrian Grzybowski

Chief Scientific Officer
AnuBio
 

Andrea Costanzo

ARDMS OBGYN

Andrea Costanzo

ARDMS OBGYN

Andrea Costanzo

ARDMS OBGYN
Innovation Incubator Finalists
Welcome Remarks

Author:

Dave Cooney

Head of GTM Strategy
Helix AI

David Cooney is the Head of GTM strategy at HelixAI and former Strategic Client Partner at Causaly AI and former Associate Partner at McKinsey, focused on AI in life sciences R&D. He has led GTM strategy, value proposition design, and enterprise partnerships across top-20 pharma, building multimillion-dollar pipelines and shaping AI product-packaging and partnership 

Dave Cooney

Head of GTM Strategy
Helix AI

David Cooney is the Head of GTM strategy at HelixAI and former Strategic Client Partner at Causaly AI and former Associate Partner at McKinsey, focused on AI in life sciences R&D. He has led GTM strategy, value proposition design, and enterprise partnerships across top-20 pharma, building multimillion-dollar pipelines and shaping AI product-packaging and partnership 

Moderator

Author:

Venkatesh Moktali, PhD

Director, Product Management, Knowledge Bases
QIAGEN Digital Insights

Venkatesh Moktali, PhD

Director, Product Management, Knowledge Bases
QIAGEN Digital Insights

Author:

Joseph Pearson

Director, Global Product Management OmicSoft
QIAGEN Digital Insights

Joseph Pearson

Director, Global Product Management OmicSoft
QIAGEN Digital Insights

Author:

Ethan Pickering

Head, Data Science & ML Research
Bayer

Ethan Pickering

Head, Data Science & ML Research
Bayer

Author:

Peter Clark

Vice President, Digital Chemistry & Design
Novo Nordisk RDUS

Peter Clark

Vice President, Digital Chemistry & Design
Novo Nordisk RDUS